625 related articles for article (PubMed ID: 18546811)
1. Five-year clinical and histologic results following treatment of human intrabony defects with an enamel matrix derivative combined with a natural bone mineral.
Sculean A; Chiantella GC; Arweiler NB; Becker J; Schwarz F; Stavropoulos A
Int J Periodontics Restorative Dent; 2008 Apr; 28(2):153-61. PubMed ID: 18546811
[TBL] [Abstract][Full Text] [Related]
2. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
3. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
[TBL] [Abstract][Full Text] [Related]
4. Effect of platelet-rich plasma on the healing of intrabony defects treated with an enamel matrix protein derivative and a natural bone mineral.
Döri F; Nikolidakis D; Húszár T; Arweiler NB; Gera I; Sculean A
J Clin Periodontol; 2008 Jan; 35(1):44-50. PubMed ID: 18034853
[TBL] [Abstract][Full Text] [Related]
5. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
[TBL] [Abstract][Full Text] [Related]
6. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
Velasquez-Plata D; Scheyer ET; Mellonig JT
J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
[TBL] [Abstract][Full Text] [Related]
7. Four-year results of a prospective-controlled clinical study evaluating healing of intra-bony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass.
Sculean A; Pietruska M; Arweiler NB; Auschill TM; Nemcovsky C
J Clin Periodontol; 2007 Jun; 34(6):507-13. PubMed ID: 17451415
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
Döri F; Arweiler N; Gera I; Sculean A
J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects.
Sculean A; Windisch P; Szendröi-Kiss D; Horváth A; Rosta P; Becker J; Gera I; Schwarz F
J Periodontol; 2008 Oct; 79(10):1991-9. PubMed ID: 18834256
[TBL] [Abstract][Full Text] [Related]
10. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
[TBL] [Abstract][Full Text] [Related]
11. Nine-year results following treatment of intrabony periodontal defects with an enamel matrix derivative: report of 26 cases.
Sculean A; Schwarz F; Chiantella GC; Arweiler NB; Becker J
Int J Periodontics Restorative Dent; 2007 Jun; 27(3):221-9. PubMed ID: 17694945
[TBL] [Abstract][Full Text] [Related]
12. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
[TBL] [Abstract][Full Text] [Related]
13. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
Yilmaz S; Cakar G; Yildirim B; Sculean A
J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
[TBL] [Abstract][Full Text] [Related]
14. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
[TBL] [Abstract][Full Text] [Related]
15. Intentional reim plantation of a tooth with severe periodontal involvement using enamel matrix derivative in combination with guided tissue regeneration and bone grafting: a case report.
Sugai K; Sato S; Suzuki K; Ito K
Int J Periodontics Restorative Dent; 2008 Feb; 28(1):89-94. PubMed ID: 18351207
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative (Emdogain).
Sculean A; Chiantella GC; Windisch P; Donos N
Int J Periodontics Restorative Dent; 2000 Aug; 20(4):374-81. PubMed ID: 11203577
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
Gurinsky BS; Mills MP; Mellonig JT
J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
Sculean A; Barbé G; Chiantella GC; Arweiler NB; Berakdar M; Brecx M
J Periodontol; 2002 Apr; 73(4):401-8. PubMed ID: 11990441
[TBL] [Abstract][Full Text] [Related]
19. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
20. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
Mengel R; Schreiber D; Flores-de-Jacoby L
J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
